Phillip Altman BPharm(Hons), MSc, PhD cross-posted a post from James Roguski
phillip.altman Aug 7 · Phillip Altman BPharm(Hons), MSc, PhD The whole world knows the truth......take these shots off the market.
THIS IS NOT GOOD ENOUGH The HHS just admitted that the mRNA platform is NOT safe and NOT effective. Who is going to be held accountable for all the adverse events, disabilities and deaths caused by these biological weapons? JAMES ROGUSKI AUG 7
Upgrade to paid The Department of Health and Human Services just admitted that mRNA injections are not safe and they do not work.
Yet, these biological weapons remain on the market and are still being injected into people.
TAKE THE DAMN mRNA JABS OFF THE FREAKIN’ MARKET!
“As the pandemic showed us, mRNA vaccines don’t perform well against viruses that infect the upper respiratory tract.”
“The vaccine paradoxically encourages new mutations and can actually prolong pandemics as the virus constantly mutates to escape the protective effects of the vaccine.”
“After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risks than benefits for these respiratory viruses.
“Going forward, BARDA will focus on platforms with stronger safety records and transparent clinical and manufacturing data practices.”
“BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu.”
“Some final-stage contracts (e.g., Arcturus and Amplitude) will be allowed to run their course to preserve prior taxpayer investment.”
HHS Winds Down mRNA Vaccine Development Under BARDA
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) today announced the beginning of a coordinated wind-down of its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA), including the cancellation and de-scoping of various contracts and solicitations. The decision follows a comprehensive review of mRNA-related investments initiated during the COVID-19 public health emergency.
“We reviewed the science, listened to the experts, and acted,” said HHS Secretary Robert F. Kennedy, Jr. “BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We’re shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.”
The wind-down affects a range of programs including:
Cancellation of BARDA’s award to Moderna/UTMB for an mRNA-based H5N1 vaccine. Termination of contracts with Emory University and Tiba Biotech. De-scoping of mRNA-related work in existing contracts with Luminary Labs, ModeX, and Seqirus. Rejection or cancellation of multiple pre-award solicitations, including proposals from Pfizer, Sanofi Pasteur, CSL Seqirus, Gritstone, and others, as part of BARDA’s Rapid Response Partnership Vehicle (RRPV) and VITAL Hub. Restructuring of collaborations with DoD-JPEO, affecting nucleic acid-based vaccine projects with AAHI, AstraZeneca, and HDT Bio. While some final-stage contracts (e.g., Arcturus and Amplitude) will be allowed to run their course to preserve prior taxpayer investment, no new mRNA-based projects will be initiated. HHS has also instructed its partner, Global Health Investment Corporation (GHIC), which manages BARDA Ventures, to cease all mRNA-based equity investments. In total, this affects 22 projects worth nearly $500 million. Other uses of mRNA technology within the department are not impacted by this announcement.
“Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them. That’s why we’re moving beyond the limitations of mRNA and investing in better solutions,” said Secretary Kennedy.
The move signals a broader shift in federal vaccine development priorities. Going forward, BARDA will focus on platforms with stronger safety records and transparent clinical and manufacturing data practices. Technologies that were funded during the emergency phase but failed to meet current scientific standards will be phased out in favor of evidence-based, ethically grounded solutions – like whole-virus vaccines and novel platforms.
NOT Safe And NOT Effective DECEMBER 26, 2024 NOT Safe And NOT Effective Share this link: NotSafeAndNotEffective.com
Read full story STOP HARMING OUR CHILDREN JAMES ROGUSKI · MAR 2 STOP HARMING OUR CHILDREN Please start by watching the brief video below:
Read full story Legalized Democide JAMES ROGUSKI · AUG 3 Legalized Democide The PREP Act, along with the 12 amendments to the original COVID-19 PREP Act “Declaration” and numerous other laws have effectively enabled the United States government and the Pharmaceutical, Hospital, Emergency Industrial Complex (PHEIC) to harm, disable and kill Americans without concern for lawsuit or liability.
这还不够好
HHS刚刚承认mRNA平台不安全，也不有效。谁将对这些生物武器造成的所有不良事件、残疾和死亡负责？
Phillip Altman BPharm(Hons), MSc, PhD cross-posted a post from James Roguski
phillip.altman
Aug 7 · Phillip Altman BPharm(Hons), MSc, PhD
The whole world knows the truth......take these shots off the market.
THIS IS NOT GOOD ENOUGH
The HHS just admitted that the mRNA platform is NOT safe and NOT effective. Who is going to be held accountable for all the adverse events, disabilities and deaths caused by these biological weapons?
JAMES ROGUSKI
AUG 7
https://open.substack.com/pub/jamesroguski/p/this-is-not-good-enough
READ IN APP
Share
Leave a comment
Upgrade to paid
The Department of Health and Human Services just admitted that mRNA injections are not safe and they do not work.
Yet, these biological weapons remain on the market and are still being injected into people.
TAKE THE DAMN mRNA JABS OFF THE FREAKIN’ MARKET!
“As the pandemic showed us, mRNA vaccines don’t perform well against viruses that infect the upper respiratory tract.”
“The vaccine paradoxically encourages new mutations and can actually prolong pandemics as the virus constantly mutates to escape the protective effects of the vaccine.”
“After reviewing the science and consulting top experts at NIH and FDA, HHS has determined that mRNA technology poses more risks than benefits for these respiratory viruses.
“Going forward, BARDA will focus on platforms with stronger safety records and transparent clinical and manufacturing data practices.”
“BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu.”
“Some final-stage contracts (e.g., Arcturus and Amplitude) will be allowed to run their course to preserve prior taxpayer investment.”
HHS Winds Down mRNA Vaccine Development Under BARDA
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) today announced the beginning of a coordinated wind-down of its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA), including the cancellation and de-scoping of various contracts and solicitations. The decision follows a comprehensive review of mRNA-related investments initiated during the COVID-19 public health emergency.
“We reviewed the science, listened to the experts, and acted,” said HHS Secretary Robert F. Kennedy, Jr. “BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We’re shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.”
The wind-down affects a range of programs including:
Cancellation of BARDA’s award to Moderna/UTMB for an mRNA-based H5N1 vaccine.
Termination of contracts with Emory University and Tiba Biotech.
De-scoping of mRNA-related work in existing contracts with Luminary Labs, ModeX, and Seqirus.
Rejection or cancellation of multiple pre-award solicitations, including proposals from Pfizer, Sanofi Pasteur, CSL Seqirus, Gritstone, and others, as part of BARDA’s Rapid Response Partnership Vehicle (RRPV) and VITAL Hub.
Restructuring of collaborations with DoD-JPEO, affecting nucleic acid-based vaccine projects with AAHI, AstraZeneca, and HDT Bio.
While some final-stage contracts (e.g., Arcturus and Amplitude) will be allowed to run their course to preserve prior taxpayer investment, no new mRNA-based projects will be initiated. HHS has also instructed its partner, Global Health Investment Corporation (GHIC), which manages BARDA Ventures, to cease all mRNA-based equity investments. In total, this affects 22 projects worth nearly $500 million. Other uses of mRNA technology within the department are not impacted by this announcement.
“Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them. That’s why we’re moving beyond the limitations of mRNA and investing in better solutions,” said Secretary Kennedy.
The move signals a broader shift in federal vaccine development priorities. Going forward, BARDA will focus on platforms with stronger safety records and transparent clinical and manufacturing data practices. Technologies that were funded during the emergency phase but failed to meet current scientific standards will be phased out in favor of evidence-based, ethically grounded solutions – like whole-virus vaccines and novel platforms.
https://www.hhs.gov/press-room/hhs-winds-down-mrna-development-under-barda.html
NOT Safe And NOT Effective
DECEMBER 26, 2024
NOT Safe And NOT Effective
Share this link: NotSafeAndNotEffective.com
Read full story
STOP HARMING OUR CHILDREN
JAMES ROGUSKI
·
MAR 2
STOP HARMING OUR CHILDREN
Please start by watching the brief video below:
Read full story
Legalized Democide
JAMES ROGUSKI
·
AUG 3
Legalized Democide
The PREP Act, along with the 12 amendments to the original COVID-19 PREP Act “Declaration” and numerous other laws have effectively enabled the United States government and the Pharmaceutical, Hospital, Emergency Industrial Complex (PHEIC) to harm, disable and kill Americans without concern for lawsuit or liability.
Read full story
James Roguski
310-619-3055
JamesRoguski.substack.com/archive
Phillip Altman Bpharm（Hons），MSC，博士发布了来自James Roguski Phillip.altman 8月7·Phillip Altman Bpharm（Hons），MSC，博士整个世界都知道真相......带上这些 这不足以足够的HHS刚刚承认MRNA平台不安全而无效。 谁将对这些生物武器造成的所有不良事件，残疾和死亡负责？ James Roguski 8月7日阅读App Share留言发表评论升级到支付的卫生部和人类服务部门刚刚承认，mRNA注射不安全，他们不起作用。 然而，这些生物武器仍在市场上，仍然被注入人民。 把该死的mrna jabs脱掉弗雷肯的市场！ “随着大流行表明我们，mRNA疫苗对感染上呼吸道的病毒表现不佳。” “疫苗矛盾促进新的突变，实际上可以延长病毒不断突变以逃避疫苗的保护作用。” “在审查NIH和FDA的科学和咨询顶级专家后，HHS已确定MRNA技术在这些呼吸道病毒的益处造成更多风险。 “展望未来，Barda将专注于具有更强安全记录和透明临床和制造数据实践的平台。” “Barda正在终止22例mRNA疫苗开发投资，因为数据显示这些疫苗未能有效地保护Covid和流感等上呼吸道感染。” “一些最终阶段的合同（例如，Arcturus和幅度）将被允许运行他们的课程以保存先前的纳税人投资。” HHS在Barda Washington，D.C中浏览MRNA疫苗开发。 - 美国卫生和人类服务部（HHS）今天宣布，在生物医学的先进研究中宣布协调其mRNA疫苗开发活动的协调下降 该决定遵循在Covid-19公共卫生紧急情况下发起的MRNA相关投资的全面审查。 “我们审查了科学，听取专家，并采取行动，”HHS秘书罗伯特F.肯尼迪，JR。“Barda终止了22例MRNA疫苗开发投资，因为数据显示这些疫苗未能有效保护上呼吸 我们正在转向更安全的更广泛的疫苗平台，即使是病毒变异而仍然有效的资金。“ 危机会影响一系列计划，包括：将Barda的奖励取消对现代的MRNA / UTMB的MRNA的H5N1疫苗。 与埃米利大学和TIBA BIOTECH合同终止。 与Luminary Labs，Modex和Seqirus的现有合同中的MRNA相关工作的解除裁视。 拒绝或取消多个预奖项，包括来自辉瑞，萨诺伊巴斯德，CSL Seqirus，Gritstone等的提案，作为Barda的快速反应伙伴关系（RRPV）和重要枢纽的一部分。 用DoD-JPEO的合作重组，影响Aahi，Astazeneca和HDT生物的基于核酸的疫苗项目。 虽然一些最终阶段的合同（例如，Arcturus和幅度）将被允许运行他们的课程以保存先前的纳税人投资，但不会启动新的MRNA的项目。 HHS还指示其合作伙伴，全球卫生投资公司（GHIC），用于停止所有MRNA的股权投资。 总的来说，这影响了22个价值近5亿美元的项目。 该公告不受该部门内部MRNA技术的其他用途。 “让我绝对清楚：HHS支持每个想要他们的美国人安全，有效的疫苗。 这就是为什么我们超越MRNA的局限性并投资更好的解决方案，“秘书长肯尼迪表示。 移动信号在联邦疫苗开发优先事项中更广泛。 展望未来，Barda将专注于具有更强安全记录和透明临床和制造数据实践的平台。 在紧急阶段进行资助但未能达到当前科学标准的技术将逐步支持基于证据的道德接地解决方案 - 像整个病毒疫苗和新颖的平台。 https://www.hhs.gov/press-roroom/hhs-winds-down-mrna-development-under-barda.html不安全而不是以安全而非生效的12月26日，2024不安全且不有效分享此链接：尚未安全 阅读完整故事James Roguski 310-619-3055 JamesRoguski.substack.com/Archive